The treatment for multiple myeloma makes you feel extremely fatigued, can cause nausea, diarrhea and an increased susceptibility to infections due to having a weakened a immune system.
People who are treated for multiple myeloma cancer often experience nerve pain, which peripheral neuropathy, hair loss as well as chemo brain.
And the steroids, which are a common component of multiple myeloma treatment, can cause mood swings, insomnia and fluid retention.
The intense fatigue from multiple myeloma treatment, may not improve with rest.
You may also experience vomiting and constipation and have problems sleeping, mouth sores, and pain and tingling and numbness in the feet and hands with multiple myeloma.
The treatment for multiple myeloma often involves a combination of targeted therapies, immunomodulatory agents like lenalidomide, proteasome inhibitors like bortezomib, steroids and also autologous stem cell transplants.
Multiple myeloma cancer is a cancer of the bone marrow plasma cells, which cause abnormal protein buildup of M protein, which results in bone lesions, kidney damage, anemia and immune system suppression.
Multiple myeloma cancer is considered to be incurable, although multiple myeloma is also highly treatable, especially when caught early.
New therapies for multiple myeloma improve your prognosis significantly and allow you to live active lives.
Common symptoms of multiple myeloma are bone pain, especially in the back or the ribs, fatigue, frequent infections and high calcium levels.
The exact cause of multiple myeloma is not know, although multiple myeloma also involves genetic mutations in the plasma cells, which cause them to grow uncontrollably.
Risk factors for multiple myeloma include being male, being over age 65, being of African American heritage, being obese and having a family history of multiple myeloma.
Multiple myeloma often develops from a precursor condition that is called monoclonal gammopathy of undetermined significance.
Multiple myeloma is often diagnosed through blood and urine tests to check for M protein, along with bone marrow biopsies and imaging tests like MRI, CT and PET scans to assess for bone damage.
The treatment for multiple myeloma often involves a combination of targeted therapies, immunomodulatory agents like lenalidomide, proteasome inhibitors like bortezomib, steroids and also autologous stem cell transplants.